CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity
Authors:
Open Access
- 4 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 798087
Abstract
The generation and expansion of functionally competent NK cells in vitro is of great interest for their application in immunotherapy of cancer. Since CD33 constitutes a promising target for immunotherapy of myeloid malignancies, NK cells expressing a CD33-specific chimeric antigen receptor (CAR) were generated. Unexpectedly, we noted that CD33-CAR NK cells could not be efficiently expanded in vitro due to a fratricide-like process in which CD33-CAR NK cells killed other CD33-CAR NK cells that had upregulated CD33 in culture. This upregulation was dependent on the stimulation protocol and encompassed up to 50% of NK cells including CD56dim NK cells that do generally not express CD33 in vivo. RNAseq analysis revealed that upregulation of CD33+ NK cells was accompanied by a unique transcriptional signature combining features of canonical CD56bright (CD117high, CD16low) and CD56dim NK cells (high expression of granzyme B and perforin). CD33+ NK cells exhibited significantly higher mobilization of cytotoxic granula and comparable levels of cytotoxicity against different leukemic target cells compared to the CD33− subset. Moreover, CD33+ NK cells showed superior production of IFNγ and TNFα, whereas CD33− NK cells exerted increased antibody-dependent cellular cytotoxicity (ADCC). In summary, the study delineates a novel functional divergence between NK cell subsets upon in vitro stimulation that is marked by CD33 expression. By choosing suitable stimulation protocols, it is possible to preferentially generate CD33+ NK cells combining efficient target cell killing and cytokine production, or alternatively CD33− NK cells, which produce less cytokines but are more efficient in antibody-dependent applications.Keywords
Funding Information
- European Regional Development Fund ((ERDF, German EFRE) 2014-2020, iCAN33)
This publication has 30 references indexed in Scilit:
- Peripheral natural killer cell maturation depends on the transcription factor AiolosThe EMBO Journal, 2014
- Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCsBlood, 2014
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)Blood, 2013
- Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and functionCancer Immunology, Immunotherapy, 2011
- Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell educationBlood, 2010
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- The extended human leukocyte receptor complex: diverse ways of modulating immune responsesImmunological Reviews, 2008
- Human natural killer cellsBlood, 2008
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cellsImmunology Letters, 1993